1. Home
  2. APLS vs OII Comparison

APLS vs OII Comparison

Compare APLS & OII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • OII
  • Stock Information
  • Founded
  • APLS 2009
  • OII 1964
  • Country
  • APLS United States
  • OII United States
  • Employees
  • APLS N/A
  • OII N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • OII Oilfield Services/Equipment
  • Sector
  • APLS Health Care
  • OII Energy
  • Exchange
  • APLS Nasdaq
  • OII Nasdaq
  • Market Cap
  • APLS 2.3B
  • OII 2.2B
  • IPO Year
  • APLS 2017
  • OII N/A
  • Fundamental
  • Price
  • APLS $17.30
  • OII $19.05
  • Analyst Decision
  • APLS Buy
  • OII Hold
  • Analyst Count
  • APLS 19
  • OII 5
  • Target Price
  • APLS $39.06
  • OII $28.00
  • AVG Volume (30 Days)
  • APLS 2.7M
  • OII 931.9K
  • Earning Date
  • APLS 05-07-2025
  • OII 04-23-2025
  • Dividend Yield
  • APLS N/A
  • OII N/A
  • EPS Growth
  • APLS N/A
  • OII 67.93
  • EPS
  • APLS N/A
  • OII 1.78
  • Revenue
  • APLS $775,839,000.00
  • OII $2,736,592,000.00
  • Revenue This Year
  • APLS $12.25
  • OII $4.95
  • Revenue Next Year
  • APLS $21.08
  • OII $3.37
  • P/E Ratio
  • APLS N/A
  • OII $10.67
  • Revenue Growth
  • APLS 48.04
  • OII 10.04
  • 52 Week Low
  • APLS $16.65
  • OII $15.46
  • 52 Week High
  • APLS $43.99
  • OII $30.98
  • Technical
  • Relative Strength Index (RSI)
  • APLS 34.14
  • OII 52.96
  • Support Level
  • APLS $16.65
  • OII $18.27
  • Resistance Level
  • APLS $20.75
  • OII $18.89
  • Average True Range (ATR)
  • APLS 1.09
  • OII 0.76
  • MACD
  • APLS 0.14
  • OII 0.27
  • Stochastic Oscillator
  • APLS 15.85
  • OII 82.84

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About OII Oceaneering International Inc.

Oceaneering International Inc is a global provider of engineered services and products robotic solutions to the offshore energy, defense, aerospace, manufacturing and entertainment industries. Most of Oceaneering's products are produced for the offshore oil and gas market. It had a 2020 segment realignment to promote synergies and cost efficiency. The five segments are subsea robotics; manufactured products; offshore projects group; integrity management and digital solutions; and aerospace and defense technologies. Within the segments are two businesses - services and products provided primarily to the oil and gas industry. The firm is also involved in the offshore renewables and mobility solutions industries.

Share on Social Networks: